Invion Limited (ASX:IVX)
0.0400
0.00 (0.00%)
Sep 7, 2026, 3:35 PM AEST
Invion Market Cap
Invion has a market cap or net worth of 4.37 million as of September 4, 2026. Its market cap has decreased by -59.20% in one year.
Market Cap
4.37M
Enterprise Value
5.32M
Revenue
384.71K
Ranking
n/a
PE Ratio
n/a
Stock Price
0.04
ChartMarket Cap Chart
Since February 15, 2010, Invion's market cap has decreased from 23.91M to 4.37M, a decrease of -81.73%. That is a compound annual growth rate of -9.75%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 7, 2026 | 4.37M | -45.16% |
| Dec 30, 2025 | 7.97M | -58.93% |
| Dec 31, 2024 | 19.39M | -39.60% |
| Dec 29, 2023 | 32.11M | -44.43% |
| Dec 30, 2022 | 57.78M | -57.12% |
| Dec 31, 2021 | 134.75M | 143.32% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Syntara | 51.01M |
| Peak Processing | 20.60M |
| IDT Australia | 19.66M |
| Vitura Health | 17.89M |
| Epsilon Healthcare | 10.12M |
| ECS Botanics Holdings | 9.58M |
| Cann Group | 8.30M |
| Percheron Therapeutics | 7.61M |